The potential mechanisms underlying these two types of resistances include the lack of immune cell infiltration in the TME, aberrant PD-L1 expression, and genetic or epigenetic alterations that affect tumor antigen presentation [53,54,55]. Here, CD274 is linked to neoplasm.